journal article·2026-09Open access

Binuclear [Cu(bipyridine)(NO3)(OH)]2 complex: Structural characterization, DFT calculations, molecular docking, and cytotoxicity against breast adenocarcinoma cells

Kamila R. Abreu, João G. de Oliveira Neto, Jailton R. Viana, Otávio C. da Silva Neto, Luna N. Vasconcelos, Ana P.S. de A. dos Santos, Mateus R. Lage, Francisco F. de Sousa, Eliana B. Souto, Adenilson O. dos Santos

Abstract

Copper(II) complexes with aromatic N-heterocyclic ligands have attracted considerable attention as potential anticancer agents due to their capacity to interact with DNA and inhibit tumor cell proliferation. Despite the structural characterization of the binuclear [Cu(Bipyridine)(NO 3 )(OH)] 2 complex reported nearly three decades ago, its physicochemical and biological landscape remained largely unexplored. In the present work, a comprehensive characterization of this complex is reported, encompassing experimental and computational approaches. The complex was synthesized by slow solvent evaporation and confirmed by powder X-ray diffraction (PXRD) with Rietveld refinement, which established a triclinic structure (space group , Z = 1) with lattice parameters in good agreement with literature values (ΔV = 0.44%). Ultraviolet-visible spectroscopy revealed a d-d transition at 641 nm, from which a crystal field splitting parameter of 10Dq ≈ 15,601 cm –1 was estimated, confirming the stronger ligand field of 2,2-bipyridine relative to water. Density functional theory (DFT) calculations using the PBE1PBE functional in vacuum, water, and methanol revealed the triplet state as the most stable configuration and demonstrated a solvation-dependent increase in the HOMO-LUMO gap (3.40 eV in vacuum; 4.65 eV in water), reflecting enhanced electronic stability under physiological conditions. High electrophilicity values ( ϖ = 5.05-5.51 eV) support the potential for interactions with biological nucleophiles. Hirshfeld surface analysis quantified the dominant intermolecular interactions in the crystal lattice, with H···O/O···H contacts accounting for 41.1% of the surface. A group-theory-based normal mode analysis provided suitable assignment of the observed modes, with strong agreement between experimental and DFT-calculated spectra. Thermal analysis demonstrated stability up to 473 K, confirmed by variable-temperature PXRD up to 620 K. Molecular docking revealed affinity for DNA ( K i = 6.27 μM, PDB: 1BNA) and the breast cancer-associated 3α-hydroxysteroid dehydrogenase type 3 enzyme ( K i = 36.69 μM, PDB: 4XO6). In silico pharmacokinetics profiling indicated limited oral bioavailability due to high topological polar surface area (TPSA = 169.18 Å 2 ), though favorable water solubility (Log S = 0.31) and absence of CYP450 inhibition suggest low hepatotoxicity risk. Cytotoxicity assays yielded IC 50 values of 39.73 μM and 14.46 μM against MCF-7 breast adenocarcinoma and GM07492A healthy fibroblast cell lines, respectively, with a selectivity index of 0.36. These results establish [Cu(Bipyridine)(NO 3 )(OH)] 2 as a biologically relevant binuclear Cu(II) candidate whose tumor selectivity may be improved through targeted nanoencapsulation strategies.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Metal complexes synthesis and properties · Metal-Organic Frameworks: Synthesis and Applications · Crystal structures of chemical compounds

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (95)

Show source-provided references
1. Ruthenium metallopharmaceuticals10.1016/S0010-8545(02)00312-0 ↗
2. Interactions of Metal−Metal-Bonded antitumor active complexes with DNA fragments and DNA10.1021/ar0302078 ↗
3. Mixed-Ligand Copper(II)-phenolate complexes: effect of coligand on enhanced DNA and protein binding, DNA cleavage, and anticancer activity10.1021/ic700755p ↗
4. Experimental and computational study of Ni(II) and Zn(II) complexes of isatin-3-thiosemicarbazone: structure, biological activity and ct-DNA binding study10.1016/j.molstruc.2025.141846 ↗
5. Metallodrugs: synthesis, mechanism of action and nanoencapsulation for targeted chemotherapy10.1016/j.bcp.2024.116644 ↗
6. Synthesis, crystal structure, cytotoxic activities and DNA-binding properties of new binuclear copper(II) complexes bridged by N,N′-bis(N-hydroxyethylaminoethyl)oxamide10.1016/j.jinorgbio.2009.02.007 ↗
7. Recognition and reaction of metallointercalators with DNA10.1021/cr9804341 ↗
8. Structure, recognition, and processing of Cisplatin−DNA adducts10.1021/cr980421n ↗
9. Synthesis, X-ray structure, vibrational spectroscopy, DFT, biological evaluation and molecular docking studies of (E)-N′-(4-(dimethylamino)benzylidene)-5-methyl-1H-pyrazole-3-carbohydrazide10.1016/j.molstruc.2020.128541 ↗
10. Synthesis, characterization and DNA-binding studies of cobalt(III) polypyridyl complexes10.1016/S0277-5387(01)00924-X ↗
11. Effects of ligand planarity on the interaction of polypyridyl Ru(ii) complexes with DNA10.1039/b300353a ↗
12. Effects of the ancillary ligands of polypyridyl ruthenium(ii) complexes on the DNA-binding behaviors10.1039/b212826h ↗
13. Thermodynamic and spectroscopic study on the binding of cationic Zn(ii) and Co(ii) tetrapyridinoporphyrazines to calf thymus DNA: the role of the central metal in binding parameters10.1039/b404068f ↗
14. New binuclear Cu (II) complex: synthesis, structural elucidation, cytotoxic and DNA-binding evaluation10.1007/s11243-023-00561-8 ↗
15. Copper(II) complexes of terpyridine derivatives: a footstep towards development of antiproliferative agent for breast cancer10.1016/j.jinorgbio.2012.08.010 ↗
16. DNA hydrolysis promoted by di- and multi-nuclear metal complexes10.1016/j.cct.2003.11.002 ↗
17. Amphiphilic Cu(II) oxacyclen complexes: from oxidative cleavage to condensation of DNA10.1002/cbic.202500477 ↗
18. The effect of potential supramolecular-bond promoters on the DNA-interacting abilities of copper–terpyridine compounds10.1039/C5DT02211H ↗
19. Novel mononuclear Cu (II) terpyridine complexes: impact of fused ring thiophene and thiazole head groups towards DNA/BSA interaction, cleavage and antiproliferative activity on HepG2 and triple negative CAL-51 cell line10.1016/j.ejmech.2017.04.030 ↗
20. Synthesis, cytotoxic activity and DNA-binding properties of copper(II) complexes with terpyridine10.1016/j.poly.2017.11.008 ↗
21. DNA and BSA binding and cytotoxic properties of copper(ii) and iron(iii) complexes with arylhydrazone of ethyl 2-cyanoacetate or formazan ligands10.1039/C7NJ00420F ↗
22. Copper(II) mixed chelate compounds induce apoptosis through reactive oxygen species in neuroblastoma cell line CHP-21210.1016/j.jinorgbio.2013.05.001 ↗
23. Isomeric effect on the pharmacokinetic behavior of anticancer CuII mixed chelate complexes: experimental and theoretical approach
24. Design, synthesis, and evaluation of benzimidazole-carbazole hybrids targeting heat shock proteins-mediated apoptosis in breast and Colon cancer cells10.1002/ddr.70092 ↗
25. Discovery of sulfadrug–pyrrole conjugates as carbonic anhydrase and acetylcholinesterase inhibitors10.1002/ardp.202100242 ↗
26. Efficient enhancement of DNA cleavage activity by introducing guanidinium groups into diiron(III) complex10.1016/j.bmcl.2007.11.001 ↗
27. Physical and kinetic analysis of the cooperative role of metal ions in catalysis of phosphodiester cleavage by a dinuclear Zn(II) complex10.1021/ja027728v ↗
28. Theoretical, biological and in silico studies of pendant-armed heteroleptic copper(II) phenolate complexes10.1016/j.molstruc.2018.02.025 ↗
29. Synthesis, nucleic acid binding and cytotoxicity of polyethyleneimine-copper(II) complexes containing 1,10-phenanthroline and l-valine10.1016/j.ejmech.2011.04.033 ↗
30. Rhenium(I) tricarbonyl complexes of 1,10-Phenanthroline derivatives with unexpectedly high cytotoxicity10.1021/acs.inorgchem.3c00730 ↗
31. The 1,10-Phenanthroline ligand enhances the antiproliferative activity of DNA-Intercalating Thiourea-Pd(II) and -Pt(II) complexes against cisplatin-sensitive and -Resistant human ovarian cancer cell lines10.3390/ijms20246122 ↗
32. Copper(II) and silver(I)-1,10-phenanthroline-5,6-dione complexes interact with double-stranded DNA: further evidence of their apparent multi-modal activity towards Pseudomonas aeruginosa10.1007/s00775-021-01922-3 ↗
33. The chemistry of dinitrato-2, 2′-bipyridinecopper(II): preparation and characterization of binuclear complexes having a Cu(μ-OH)2Cu and Cu(μ-N3)2Cu core10.1016/S0020-1693(98)00007-3 ↗
34. Two novel copper complexes of 2,2′-bipyridine: evaluation of the DNA binding and cytotoxic activity10.1016/j.jphotobiol.2013.04.011 ↗
35. EXPGUI, a graphical user interface for GSAS10.1107/S0021889801002242 ↗
36. Quantum mechanical Continuum Solvation models10.1021/cr9904009 ↗
37. Spin propensities of octahedral complexes from density functional theory10.1021/acs.jpca.5b01626 ↗
38. Frisch · 2016
39. Thirty years of density functional theory in computational chemistry: an overview and extensive assessment of 200 density functionals10.1080/00268976.2017.1333644 ↗
40. An evaluation of harmonic vibrational frequency Scale factors10.1021/jp073974n ↗
41. Improving vibrational mode interpretation using bayesian regression10.1021/acs.jctc.8b00439 ↗
42. Morris · 2009 · vol. 30 · 2785
43. Structure of a B-DNA dodecamer: conformation and dynamics10.1073/pnas.78.4.2179 ↗
44. Drew · 1981
45. Human 3α-hydroxysteroid dehydrogenase type 3: structural clues of 5α-DHT reverse binding and enzyme down-regulation decreasing MCF7 cell growth10.1042/BCJ20160083 ↗
46. Novel Bromo and methoxy substituted Schiff base complexes of Mn(II), Fe(III), and Cr(III) for anticancer, antimicrobial, docking, and ADMET studies10.1038/s41598-023-29386-2 ↗
47. Design, synthesis, and characterization of M(II)-Schiff base complexes containing 3,5-di-tert-butyl salicylaldehyde: DNA binding/cleavage, DPPH radical scavenging activity, cytotoxic activity, and catalytic activity investigation
48. 3D computer modeling of inhibitors targeting the MCF-7 breast cancer cell line10.3389/fchem.2024.1384832 ↗
49. Investigation on chloro-bridged binuclear copper(II) complexes as potent metallodrug candidates against colon cancer via chemical and biological assessments10.1039/D3NJ05335K ↗
50. Anti-asthmatic effect of nitric oxide metallo-donor FOR8111A [cis-[Ru(bpy)2(2-MIM)(NO)](PF6)3] in the respiratory mechanics of Swiss mice10.1371/journal.pone.0248394 ↗
51. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules10.1038/srep42717 ↗
52. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings10.1016/S0169-409X(96)00423-1 ↗
53. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases10.1021/cc9800071 ↗
54. Molecular properties that influence the oral bioavailability of drug candidates10.1021/jm020017n ↗
55. Prediction of drug absorption using multivariate statistics10.1021/jm000292e ↗
56. Jones · 2001
57. Novel copper(II) complexes with hydrazides and heterocyclic bases: synthesis, structure and biological studies10.1016/j.jinorgbio.2017.04.024 ↗
58. Synthesis, physicochemical properties, DFT calculations, molecular docking, and antibacterial profile of copper crystals complexed with 1,10-phenanthroline and L-asparagine10.1016/j.molliq.2025.129145 ↗
59. The ligand field Spectra of Copper(II) complexes10.1021/ed075p98 ↗
60. A single crystal hybrid ligand framework of Copper(II) with stable intrinsic blue-light luminescence in aqueous solution10.3390/nano11092281 ↗
61. Synthesis, spectrophotometric and DFT studies of new Triazole Schiff bases as selective naked-eye sensors for acetate anion10.1080/10610278.2020.1808217 ↗
62. Vibrational spectroscopy (FT-IR and FT-Raman) investigation, and hybrid computational (HF and DFT) analysis on the structure of 2,3-naphthalenediol10.1016/j.saa.2011.09.002 ↗
63. Mixed-ligand cobalt(II) complexes of bioinorganic and medicinal relevance, involving dehydroacetic acid and β-diketones: their synthesis, hyphenated experimental-DFT, thermal and bactericidal facets10.1016/j.molstruc.2015.06.019 ↗
64. Corrosion inhibition of carbon steel in 1 M H2SO4 using new Azo Schiff compound: electrochemical, gravimetric, adsorption, surface and DFT studies10.1016/j.molliq.2020.113690 ↗
65. Recent advances in the discovery of copper(II) complexes as potential anticancer drugs10.1016/j.ejmech.2025.117702 ↗
66. Quantum chemical properties investigation and molecular docking analysis with DNA topoisomerase II of β-carboline indole alkaloids from Simaba guianensis: a combined experimental and theoretical DFT study10.1007/s11224-017-1029-5 ↗
67. Magnetic property, DFT calculation, and biological activity of bis[(μ2-chloro)chloro(1,10-phenanthroline)copper(II)] complex10.1016/j.cbi.2015.02.023 ↗
68. Generalized koopmans' Theorem10.1103/PhysRev.123.420 ↗
69. On Koopmans' theorem in density functional theory10.1063/1.3491272 ↗
70. Density functional theory studies on copper phenanthroline complexes10.1021/ic0618908 ↗
71. Electronegativity: the density functional viewpoint10.1063/1.436185 ↗
72. Molecular structures, spectroscopic (FT–IR, NMR, UV) studies, NBO analysis and NLO properties for tautomeric forms of 1,3-dimethyl-5-(phenylazo)-6-aminouracil by density functional method10.1016/j.saa.2017.07.034 ↗
73. Electrophilicity index as a possible descriptor of biological activity10.1016/j.bmc.2004.08.013 ↗
74. Experimental and computational approaches of a novel methyl (2E)-2-{[N-(2-formylphenyl)(4-methylbenzene)sulfonamido]methyl}-3-(4-chlorophenyl)prop-2-enoate: A potential antimicrobial agent and an inhibition of penicillin-binding protein10.1016/j.molstruc.2016.02.084 ↗
75. Hirshfeld surface analysis10.1039/B818330A ↗
76. Copper(II) and zinc(II) complexes with hydrazone: synthesis, crystal structure, hirshfeld surface and antibacterial activity10.1016/j.ica.2020.119632 ↗
77. Normal mode determination in crystals10.1002/jrs.1250100152 ↗
78. The infrared spectra (4000–50 cm−1) of complexes of 2,2′-Bipyridine, 1,10-Phenanthroline and their perdeuterated analogues with Metal(II) perchlorates of the first transition series10.1080/00958979209409204 ↗
79. Normal mode analysis of 2,2′-bipyridine—I. Internal modes10.1016/0584-8539(83)80063-4 ↗
80. Normal mode analysis of 2,2′-bipyridine—II. Crystal vibrations10.1016/0584-8539(83)80064-6 ↗
81. IR and Raman spectra of 2,2'-bipyridine10.1016/0301-0104(79)85204-0 ↗
82. Copper(II):phenanthroline complexes with l-asparagine and l-methionine: synthesis, crystal structure and in-vitro cytotoxic effects on prostate, breast and melanoma cancer cells10.1016/j.poly.2020.114807 ↗
83. Synthesis, characterization, DFT study, and antibacterial activity of a coordination complex of Cu(II) with 1,10-phenanthroline and l-methionine ligands10.1016/j.molstruc.2023.136197 ↗
84. Antibacterial [Zn(nicotinamide)2Cl2] complex for the treatment of skin conditions: an experimental-theoretical study of physicochemical, microbiological and in silico pharmacokinetic properties10.1016/j.molliq.2024.124846 ↗
85. Exploring thermal stability, vibrational properties, and biological assessments of Dichloro(l-histidine)copper(II): a combined theoretical and experimental study10.1021/acsomega.4c05029 ↗
86. (+)-Limonene 1,2-Epoxide-Loaded SLNs: evaluation of drug release, antioxidant activity, and cytotoxicity in an HaCaT cell line10.3390/ijms21041449 ↗
87. Interaction between chiral ions: synthesis and characterization of tartratovanadates(V) with tris(2,2′-bipyridine) complexes of iron(II) and nickel(II) as cations10.1007/s11243-014-9873-2 ↗
88. Preparation, characterization, and kinetics of thermolysis of nickel and copper nitrate complexes with 2,2′-bipyridine ligand10.1016/j.tca.2012.06.032 ↗
89. Discrete terpyridine-lanthanide molecular and supramolecular complexes10.1016/j.supmat.2022.100017 ↗
90. Thermal behaviour of the N-donor adducts of metal Saccharinates: I. 2,2'-bipyridine saccharinato complexes of Co(II), Ni(II), Cu(II), Zn(II) and Pb(II)10.1023/A:1011516316158 ↗
91. Zhang · 2024
92. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties10.1021/jm000942e ↗
93. Structural, vibrational, thermal, and cytotoxic characterization of Aqua(1,10-Phenanthroline)(L-Serinato)Copper(II) nitrate complex combined with DFT calculations10.1002/crat.202300240 ↗
94. Copper(II) complexes based on thiosemicarbazone ligand: preparation, crystal structure, Hirshfeld surface, energy framework, antiMycobacterium activity, in silico and molecular docking studies10.1016/j.jinorgbio.2021.111543 ↗
95. Synthesis, spectroscopic characterization, thermal stability and biological studies of mixed ligand complexes of gemifloxacin drug and 2,2′-bipyridine with some transition metals10.1007/s11164-015-2205-0 ↗